| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,830 |
3,977 |
$247K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,041 |
2,781 |
$143K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,443 |
1,183 |
$117K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,613 |
2,124 |
$90K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
863 |
748 |
$70K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
436 |
354 |
$59K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
327 |
283 |
$44K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
604 |
540 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
737 |
599 |
$18K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
176 |
164 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
926 |
828 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
417 |
390 |
$12K |
| 99385 |
|
64 |
58 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
104 |
87 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
77 |
65 |
$4K |
| 81025 |
|
640 |
562 |
$3K |
| 87070 |
|
401 |
378 |
$2K |
| 96127 |
|
87 |
68 |
$1K |
| 81003 |
|
452 |
409 |
$947.43 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
12 |
$687.00 |
| 81002 |
|
248 |
198 |
$634.40 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
53 |
45 |
$558.25 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
15 |
13 |
$402.08 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
17 |
15 |
$369.40 |
| 93000 |
|
14 |
12 |
$242.06 |
| 87088 |
|
16 |
12 |
$164.01 |
| 86592 |
|
14 |
12 |
$56.00 |